MEDIROM Healthcare Technologies Inc. (MRM) Fair Value 2026

MRM · Personal Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.3 /10

32 fundamental signals · 6 models active

Value Trap Risk

LOW (36/100)

Quick Summary — As of 2026-08-27, MEDIROM Healthcare Technologies Inc. (MRM) trades at $0.94, versus a $4.14 median fair value across its 6 active models — 340.0% above the current price. QOC: 6.3/10. Value Trap Risk: 36/100 (LOW). 6/13 models active.

Key Facts

Ticker
MRM
Price
$0.94
Quality Score
6.3/10
Value Trap Risk
36/100
Models Active
6/13
Last Updated
Strength: First Chicago suggests +368.6% upside with 53% confidence
Risk: Limited model coverage (6/13) may reduce confidence

Is MEDIROM Healthcare Technologies Inc. (MRM) Undervalued or Overvalued in 2026?

According to CirclFi’s 6-model valuation engine, MEDIROM Healthcare Technologies Inc. (MRM) appears undervalued as of : the median of 6 independent fair value estimates is $4.14, 340.0% above the current price of $0.94. Estimates range from $0.85 to $4.69. MRM scores 6.3/10 on fundamental quality and 36/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. MRM’s +340.0% gap is wider than that market norm. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy MEDIROM Healthcare Technologies Inc. Stock in 2026? →

What Fair Value Does Each Model Give MRM?

6 Intrinsic Value Models vs. Current Price ($0.94)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $3.87 +311.4%
Scenario · High Conviction
 $4.41 +368.6%
Intrinsic · Medium Conviction
 $0.85 -10.0%
Unlock the Full Matrix

Access 3 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 6 Models →

Cancel anytime · No contracts · Instant access

What Is MRM's Fair Value Range?

Spread across 6 independent models · $0.85 to $4.69

CirclFi's 6 active models place MEDIROM Healthcare Technologies Inc. (MRM) between $0.85 and $4.69 per share, a spread of 93% of the median. The median of that range — $4.14 — is the fair value CirclFi publishes for MRM, against a current price of $0.94.

Low · ML-RIVHigh · PWERM
$0.85median $4.14$4.69
Where the range comes from
Most bearish modelML Residual Income$0.85
Most bullish modelPWERM$4.69
Model agreement5 bullish · 1 bearishmoderate

A band of this width is typical. The methods agree on direction but weight growth, reinvestment and risk differently, so treat the median as a centre of gravity rather than a precise target.

Every figure above is one model's standalone output on MRM, not a CirclFi price target. How each model works →

What Is MEDIROM Healthcare Technologies Inc. (MRM) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, MEDIROM Healthcare Technologies Inc. is potentially undervalued at its current price of $0.94. Based on our 13-model framework, MEDIROM Healthcare Technologies Inc.'s intrinsic value is estimated at a median fair value of $4.14 — representing +340.0% implied upside — with 5 out of 6 active models confirming this thesis. Model dispersion is worth noting: PWERM targets $4.69 (+398.9%), versus ML-RIV at $0.85 (-10.0%). This +408.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About MRM?

6 of 13 models are currently active for MRM. Of these, 5 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for MRM is $4.14 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does MRM Rank in Personal Services?

Among 15 Personal Services stocks, MRM ranks #9 by Quality of Company score. CirclFi's QOC score of 6.3/10 evaluates 32 fundamental signals. A score of 6.3 indicates above-average quality.

MEDIROM Healthcare Technologies Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is MRM a Value Trap?

CirclFi's Value Trap algorithm assigns MRM a score of 36/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

6 of 13 models are active for MEDIROM Healthcare Technologies Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, MEDIROM Healthcare Technologies Inc. earns a quality score of 6.3/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +408.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MRM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MRM's 6 active models, average confidence is 33%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy MEDIROM Healthcare Technologies Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Personal Services Stocks Should You Also Analyze?

9 related Personal Services stocks with 13-model coverage

RGSRegis CorporationQOC 6.5ANDGAndersen Group Inc.QOC 5.8MEDMedifast, Inc.QOC 6.7CLIKClick Holdings LimitedQOC 5.5SCIService Corporation InternationalQOC 7.9DRORDror Ortho-Design, Inc.QOC 4.6FTDRFrontdoor, Inc.QOC 9.2BFAMBright Horizons Family Solutions Inc.QOC 8.3ROLRollins, Inc.QOC 8.9

Read investment analysis: RGS · ANDG · MED · CLIK · SCI · DROR · FTDR · BFAM · ROL

Which Other Stocks Have a Similar Quality Score to MRM?

7 companies across all industries closest to MRM’s Quality of Company score of 6.3/10.

PHATPhathom Pharmaceuticals, Inc.QOC 6.3FUNSix Flags Entertainment CorporationQOC 6.3BDSXBiodesix, Inc.QOC 6.3UAMYUnited States Antimony CorporationQOC 6.3THTarget Hospitality Corp.QOC 6.3NHTCNatural Health Trends Corp.QOC 6.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: PHAT · FUN · BDSX · UAMY · TH · NHTC · NVDA

What Else Do Investors Ask About MEDIROM Healthcare Technologies Inc.’s Valuation?

What is MEDIROM Healthcare Technologies Inc.'s intrinsic value in 2026?

CirclFi puts MEDIROM Healthcare Technologies Inc. (MRM)'s intrinsic value at $4.14 — the median of 6 independent model estimates as of 2026-08-27, ranging from $0.85 to $4.69. The Quality of Company score is 6.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MRM overvalued or undervalued right now?

At $0.94, 5 of 6 active models suggest MRM may be undervalued, while 1 indicate potential overvaluation. The median of all 6 fair value estimates is $4.14, 340.0% above the current price of $0.94 — a consensus view that MRM is undervalued. The assessment depends on which methodology best fits MEDIROM Healthcare Technologies Inc.'s business model in Personal Services.

What does a Quality of Company score of 6.3 mean for MRM?

MEDIROM Healthcare Technologies Inc.'s QOC of 6.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on MRM?

CirclFi analyzes MRM with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 6 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on MRM?

Of the 6 models currently active on MRM, PWERM is the most bullish at $4.69 per share, and ML Residual Income is the most bearish at $0.85. CirclFi's published fair value for MRM is the median of that range, $4.14, not either extreme. The gap between the two ends equals 93% of the median — a normal spread for a company of this profile. Browse stocks by value-trap risk →

Is MRM a value trap in 2026?

MEDIROM Healthcare Technologies Inc.'s Value Trap score is 36/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 6-model valuation engine, MEDIROM Healthcare Technologies Inc. (MRM) has a median fair value of $4.14 — 340.0% above the current price of $0.94 — as of 2026-08-27.” Source: circlfi.com/stock/MRM/ · Methodology
Primary sources for this MRM valuation

Market data for MRM as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 6 mathematical frameworks give you clarity on MRM.

Unlock All 6 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for MRM Unlock All 6 — $39/mo